Malvinder Mohan Singh

Last updated

Malvinder Mohan Singh
Malvinder Mohan Singh, 2011.jpg
Malvinder Mohan Singh
NationalityIndian
OccupationBusinessman
Known forChairman and CEO of Ranbaxy Laboratories

Malvinder Mohan Singh is a businessman who is now under arrest for criminal breach of trust. He, along with his brother Shivinder Mohan Singh (also under arrest), has many cases of fraud registered against him. [1] [2]

Contents

Singh is the former chairman and CEO of Ranbaxy Laboratories, an Indian pharmaceutical company that was sold to Japanese drugmaker Daiichi Sankyo. Singh resigned in 2009 after Ranbaxy posted losses and after Daiichi Sankyo decided to get more actively involved in the newly acquired Indian unit. [3]

In the early hours of 11 October 2019, Malvinder was arrested near Ludhiana, India, on account of a Rs. 740 crore fraud case against him and his brother Shivinder. [4]

Early life

Malvinder Mohan Singh is one of the sons of Dr. Parvinder Singh and the grandson of Bhai Mohan Singh, who bought Ranbaxy Laboratories from the original founders in 1952. [5] He and his brother Shivinder Singh inherited their father's 33.5% stake in Ranbaxy upon his death in 1999. The two used to be among the twenty richest people in India. [6]

Singh attended The Doon School, Dehradun, [7] and graduated with a degree in economics from St. Stephen's College, Delhi. He also received a masters of business administration (MBA) from Duke University's Fuqua School of Business. [8]

Business career

Malvinder Singh's tenure as CEO of Ranbaxy is controversial. A corporate culture of fraud prevailed under his leadership. In November 2006, Singh led a delegation to FDA headquarters to try to reverse the decision not to accept new drug applications from Ranbaxy. This attempt failed as the FDA asked Ranbaxy to turn over audits done by its outside consultant, Parexel, which the company was claiming were confidential. The meeting ended in a standoff. On 11 June 2008, Singh stunned the Indian business world by announcing that he and his brother were selling their 33.5% stake in Ranbaxy to the Japanese drugmaker Daiichi Sankyo for $2 billion. [9] [ citation needed ]

Malvinder Singh is the founder of Religare Wellness (now Fortis Healthcare). [10]

Arrest

On 10 October 2019, Malvinder and Shivinder Singh were arrested by the Delhi police Economic Offences Wing (EOW). [11] [12] The arrests took place within hours of each other. [11] The brothers were charged with criminal breach of trust, conspiracy, and cheating. Delhi police said that they were arrested under section 409 (criminal breach of trust by a public servant, banker, merchant or agent) and section 420 (cheating) of the Indian Penal Code. [13] Both brothers have denied the charges [12]

Their former company, Religare Finvest, reported the Singhs' crimes to the EOW, alleging embezzlement. [11] [12]

As of 9 February 2021, both Singh brothers remain under arrest as their judicial custody has been extended until the next hearing. [14]

Related Research Articles

Ranbaxy Laboratories Limited was an Indian multinational pharmaceutical company that was incorporated in India in 1961 and remained an entity until 2014. The company went public in 1973. Ownership of Ranbaxy changed twice over the course of its history.

Events in the year 2007 in the Republic of India.

<span class="mw-page-title-main">Dilip Shanghvi</span> Indian Businessman

Dilip Shanghvi is an Indian billionaire businessman and one of the country's richest people. He founded Sun Pharmaceuticals. The Government of India awarded him the civilian honour of the Padma Shri in 2016. India Today magazine ranked him 8th in India's most powerful people of 2017 list.

Talwinder Singh Parmar Indian militant, Canadian

Talwinder Singh Parmar was a Sikh Militant known for masterminding the 1985 Air India Flight 182 bombing, which killed 329 people. He was also the founder, leader, and Jathedar of Babbar Khalsa International, better known as Babbar Khalsa, a Sikh terrorist group involved in the Khalistan movement.

Encounter killing is a term used in India, Pakistan, Bangladesh and Sri Lanka since the late 20th century to describe extrajudicial killings by the police or the armed forces, supposedly in self-defence when they encounter suspected gangsters or terrorists. The incidents are typically described by the officers as a shootout situation. Sometimes policemen are also killed by criminals in encounters.

<span class="mw-page-title-main">Murder of Jessica Lal</span> 1999 celebrity murder in India

Jessica Lal was a model in New Delhi who was working as a celebrity barmaid at a crowded socialite party when she was shot dead at around 2.00am on 30 April 1999. Dozens of witnesses pointed to Siddharth Vashisht, also known as Manu Sharma, the son of Venod Sharma, a wealthy and influential Congress-nominated Member of Parliament from Haryana, as the murderer. Manu Sharma was later convicted for the murder and sentenced to life, but released less than a year later.

<span class="mw-page-title-main">Daiichi Sankyo</span> Japanese pharmaceutical company

Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 981.8 billion in revenue in 2019. The company owns the American biotechnology company Plexxikon, American pharmaceutical company American Regent, German biotechnology company U3 Pharma, and recently sold Ranbaxy Laboratories in India. Daiichi Sankyo Co., Ltd. is the producer of Benicar (Olmesartan), an angiotensin II receptor antagonist and top selling drug in the U.S. Global sales of Olmesartan in 2013 were 300.2 billion yen.

<span class="mw-page-title-main">Shivinder Mohan Singh</span> Indian businessman

Shivinder Mohan Singh is an Indian businessman and erstwhile billionaire with Fortis Healthcare, Religare, and Ranbaxy Laboratories. Singh was the non-executive vice chairman of Fortis Healthcare, an Indian company. He is currently under arrest for criminal breach of trust along with his brother Malvinder Mohan Singh. The two have many cases of fraud registered against them.

Saffron terror is a neologism used to describe acts of violence motivated by Hindutva. Hindu extremism is usually perpetrated by members, or alleged members, of Hindu nationalist organisations like Rashtriya Swayamsevak Sangh (RSS) or Abhinav Bharat. The term comes from the symbolic use of the saffron colour by many Hindu nationalist organisations.

Gautam Thapar is an Indian businessman who is the chairman of Avantha Group and is part of the Thapar family.

<span class="mw-page-title-main">Qnet</span> Hong Kong based multi-level marketing company

Qnet Ltd, formerly known as QuestNet and GoldQuest, is a Hong Kong-based multi-level marketing (MLM) company owned by the QI Group. QNet was founded in 1998 by Vijay Eswaran and Joseph Bismark. The company's products include energy, weight management, nutrition, personal care, home care and fashion accessories on an e-commerce platform.

Analjit Singh is the founder chairman of Max Group, a conglomerate with interests in life insurance, healthcare, and real estate. He is also the founder of Leeu Collection, an international collection of boutique hotels. He was also the Non-Executive Chairman of Vodafone India.

NSEL case relates to a payment default at the National Spot Exchange Limited that occurred in 2013 involving Financial Technologies India Ltd, when a payment default took place after a commodities market regulator, the Forward Markets Commission (FMC), directed NSEL to stop launching contracts. This led to the closure of the Exchange in July 2013.

<span class="mw-page-title-main">Randeep Guleria</span> Indian pulmonologist

Randeep Guleria is an Indian pulmonologist and the ex-director of the All India Institute of Medical Sciences, New Delhi, credited with the establishment of India's first centre for pulmonary medicines and sleep disorders at AIIMS. He was honoured by the Government of India in 2015 with Padma Shri, the fourth highest Indian civilian award. He is a part of India's COVID-19 response effort.

<span class="mw-page-title-main">Sunil Godhwani</span>

Sunil Godhwani is an Indian business executive who was associated with Religare from 2007 to 2018.

<span class="mw-page-title-main">SRL Diagnostics</span> Indian diagnostics chain

SRL Diagnostics is a diagnostics company based in India providing diagnostic services in pathology and radiology. SRL Diagnostics has its headquarters and corporate office in Gurgaon.

<span class="mw-page-title-main">Care Health Insurance</span> Indian financial services company

Care Health Insurance Limited is part of the Religare Group and a direct subsidiary of Religare Enterprises Limited (REL). Kedaara Capital is a co-promoter of the company. Care Health Insurance is an Indian health insurance company established in July 2012. The company is headquartered in Gurgaon, Haryana and operates out of 158 offices across India with 8500+ employees.

<span class="mw-page-title-main">Max Group</span> Indian conglomerate company

Max Group is an Indian conglomerate headquartered in New Delhi, operating in the fields of life insurance, healthcare, hospitality, real estate and independent senior living. It was founded in 1985 by Analjit Singh.

References

  1. "Explained: The cases against Religare ex-romoters Malvinder Singh and Shivinder Singh". The Indian Express . 11 October 2019. Retrieved 31 October 2019.
  2. "Ex-Ranbaxy promoters Malvinder, Shivinder Singh sent to police custody". The Times of India . Retrieved 31 October 2019.
  3. "UPDATE1-Daiichi Sankyo replaces head of its Ranbaxy unit". Reuters. 24 May 2009. Retrieved 6 April 2013. Daiichi Sankyo has since sold the company to Sun Pharmaceutical
  4. "Ranbaxy Ex-Promoters Malvinder, Shivinder Singh Arrested In Fraud Case". NDTV.com. Retrieved 11 October 2019.
  5. Bhandari, Bhupesh (22 October 2014). "40 Years Ago... And now: Ranbaxy grew with liberal regimes, moving out of family control". Business Standard India. Retrieved 16 December 2014.
  6. Forbes.com: India's Richest 2004
  7. "Class Up at Doon | Anjali Puri". Outlookindia.com. Retrieved 6 April 2013.
  8. "Singh Brothers Fraud: Ranbaxy to ruins: How the Singh brothers turned from business whizkids to fraud accused". The Economic Times.
  9. "Ranbaxy heir sells family firm in "emotional" deal". Reuters. 12 June 2008. Retrieved 18 December 2021.
  10. "Malvinder & Shivinder Singh". Forbes. Retrieved 18 December 2021.
  11. 1 2 3 WebDesk, Tehelka. "Delhi police arrests ex- Ranbaxy promoter Malvinder Singh, hours after brother Shivinder's arrest | Tehelka". tehelka.com. Retrieved 12 November 2019.
  12. 1 2 3 "India pharma brothers arrested over '$330m fraud'". 11 October 2019. Retrieved 12 November 2019.
  13. Das, Shaswati (11 October 2019). "Late night chase ends, Delhi police formally arrests Malvinder Singh". livemint.com. Retrieved 11 October 2019.
  14. "RFL scam: Court extends till November 14 judicial custody of ex-Fortis promoters Malvinder, Shivinder". The Economic Times. 31 October 2019. Retrieved 1 November 2019.